nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—ALB—multiple sclerosis	0.215	1	CbGaD
Estropipate—Exemestane—Methylprednisolone—multiple sclerosis	0.137	0.357	CrCrCtD
Estropipate—Exemestane—Prednisone—multiple sclerosis	0.125	0.326	CrCrCtD
Estropipate—Exemestane—Prednisolone—multiple sclerosis	0.122	0.318	CrCrCtD
Estropipate—SLC22A1—Cladribine—multiple sclerosis	0.0865	0.356	CbGbCtD
Estropipate—ALB—Prednisone—multiple sclerosis	0.0307	0.126	CbGbCtD
Estropipate—CYP3A4—Fingolimod—multiple sclerosis	0.0247	0.101	CbGbCtD
Estropipate—CYP3A4—Methylprednisolone—multiple sclerosis	0.0159	0.0653	CbGbCtD
Estropipate—ALB—Methotrexate—multiple sclerosis	0.0154	0.0633	CbGbCtD
Estropipate—CYP3A4—Triamcinolone—multiple sclerosis	0.012	0.0495	CbGbCtD
Estropipate—CYP3A4—Mitoxantrone—multiple sclerosis	0.0116	0.0476	CbGbCtD
Estropipate—CYP2C9—Dexamethasone—multiple sclerosis	0.0103	0.0425	CbGbCtD
Estropipate—CYP3A4—Betamethasone—multiple sclerosis	0.0103	0.0425	CbGbCtD
Estropipate—CYP3A4—Prednisolone—multiple sclerosis	0.0102	0.0419	CbGbCtD
Estropipate—CYP3A4—Prednisone—multiple sclerosis	0.00963	0.0396	CbGbCtD
Estropipate—CYP3A4—Dexamethasone—multiple sclerosis	0.00601	0.0247	CbGbCtD
Estropipate—Breast disorder—Methotrexate—multiple sclerosis	0.000134	0.001	CcSEcCtD
Estropipate—Hypersensitivity—Azathioprine—multiple sclerosis	0.000133	0.000999	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000133	0.000999	CcSEcCtD
Estropipate—Nausea—Cladribine—multiple sclerosis	0.000132	0.00099	CcSEcCtD
Estropipate—Vertigo—Prednisolone—multiple sclerosis	0.000132	0.00099	CcSEcCtD
Estropipate—Eye disorder—Dexamethasone—multiple sclerosis	0.000132	0.000987	CcSEcCtD
Estropipate—Eye disorder—Betamethasone—multiple sclerosis	0.000132	0.000987	CcSEcCtD
Estropipate—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000131	0.000984	CcSEcCtD
Estropipate—Back pain—Triamcinolone—multiple sclerosis	0.000131	0.00098	CcSEcCtD
Estropipate—Somnolence—Mitoxantrone—multiple sclerosis	0.00013	0.000974	CcSEcCtD
Estropipate—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000129	0.000965	CcSEcCtD
Estropipate—Asthma—Methotrexate—multiple sclerosis	0.000128	0.00096	CcSEcCtD
Estropipate—Angiopathy—Dexamethasone—multiple sclerosis	0.000128	0.000958	CcSEcCtD
Estropipate—Angiopathy—Betamethasone—multiple sclerosis	0.000128	0.000958	CcSEcCtD
Estropipate—Fatigue—Mitoxantrone—multiple sclerosis	0.000126	0.000945	CcSEcCtD
Estropipate—Pancreatitis—Methotrexate—multiple sclerosis	0.000126	0.000941	CcSEcCtD
Estropipate—Constipation—Mitoxantrone—multiple sclerosis	0.000125	0.000937	CcSEcCtD
Estropipate—Pain—Mitoxantrone—multiple sclerosis	0.000125	0.000937	CcSEcCtD
Estropipate—Alopecia—Betamethasone—multiple sclerosis	0.000125	0.000933	CcSEcCtD
Estropipate—Alopecia—Dexamethasone—multiple sclerosis	0.000125	0.000933	CcSEcCtD
Estropipate—Diarrhoea—Azathioprine—multiple sclerosis	0.000124	0.000928	CcSEcCtD
Estropipate—Angioedema—Triamcinolone—multiple sclerosis	0.000124	0.000926	CcSEcCtD
Estropipate—Angioedema—Methylprednisolone—multiple sclerosis	0.000123	0.000924	CcSEcCtD
Estropipate—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000123	0.000921	CcSEcCtD
Estropipate—Erythema—Dexamethasone—multiple sclerosis	0.000123	0.000919	CcSEcCtD
Estropipate—Erythema—Betamethasone—multiple sclerosis	0.000123	0.000919	CcSEcCtD
Estropipate—Vertigo—Triamcinolone—multiple sclerosis	0.000122	0.00091	CcSEcCtD
Estropipate—Vertigo—Methylprednisolone—multiple sclerosis	0.000121	0.000908	CcSEcCtD
Estropipate—Oedema—Prednisolone—multiple sclerosis	0.00012	0.000899	CcSEcCtD
Estropipate—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00012	0.000899	CcSEcCtD
Estropipate—Dysuria—Methotrexate—multiple sclerosis	0.00012	0.000898	CcSEcCtD
Estropipate—Dizziness—Azathioprine—multiple sclerosis	0.00012	0.000897	CcSEcCtD
Estropipate—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00012	0.000896	CcSEcCtD
Estropipate—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000119	0.000892	CcSEcCtD
Estropipate—Cough—Triamcinolone—multiple sclerosis	0.000118	0.000884	CcSEcCtD
Estropipate—Urticaria—Mitoxantrone—multiple sclerosis	0.000116	0.000871	CcSEcCtD
Estropipate—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000116	0.000866	CcSEcCtD
Estropipate—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000116	0.000866	CcSEcCtD
Estropipate—Myalgia—Triamcinolone—multiple sclerosis	0.000115	0.000863	CcSEcCtD
Estropipate—Vomiting—Azathioprine—multiple sclerosis	0.000115	0.000862	CcSEcCtD
Estropipate—Myalgia—Methylprednisolone—multiple sclerosis	0.000115	0.000861	CcSEcCtD
Estropipate—Arthralgia—Methylprednisolone—multiple sclerosis	0.000115	0.000861	CcSEcCtD
Estropipate—Eye disorder—Prednisone—multiple sclerosis	0.000115	0.000859	CcSEcCtD
Estropipate—Anxiety—Methylprednisolone—multiple sclerosis	0.000115	0.000858	CcSEcCtD
Estropipate—Infestation NOS—Methotrexate—multiple sclerosis	0.000114	0.000856	CcSEcCtD
Estropipate—Infestation—Methotrexate—multiple sclerosis	0.000114	0.000856	CcSEcCtD
Estropipate—Rash—Azathioprine—multiple sclerosis	0.000114	0.000855	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000114	0.000855	CcSEcCtD
Estropipate—Dermatitis—Azathioprine—multiple sclerosis	0.000114	0.000854	CcSEcCtD
Estropipate—Depression—Methotrexate—multiple sclerosis	0.000114	0.000854	CcSEcCtD
Estropipate—Headache—Azathioprine—multiple sclerosis	0.000113	0.000849	CcSEcCtD
Estropipate—Angioedema—Dexamethasone—multiple sclerosis	0.000112	0.00084	CcSEcCtD
Estropipate—Angioedema—Betamethasone—multiple sclerosis	0.000112	0.00084	CcSEcCtD
Estropipate—Angiopathy—Prednisone—multiple sclerosis	0.000111	0.000834	CcSEcCtD
Estropipate—Immune system disorder—Prednisone—multiple sclerosis	0.000111	0.000831	CcSEcCtD
Estropipate—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00011	0.000827	CcSEcCtD
Estropipate—Oedema—Triamcinolone—multiple sclerosis	0.00011	0.000827	CcSEcCtD
Estropipate—Vertigo—Betamethasone—multiple sclerosis	0.00011	0.000826	CcSEcCtD
Estropipate—Vertigo—Dexamethasone—multiple sclerosis	0.00011	0.000826	CcSEcCtD
Estropipate—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00011	0.000825	CcSEcCtD
Estropipate—Infection—Triamcinolone—multiple sclerosis	0.00011	0.000821	CcSEcCtD
Estropipate—Infection—Methylprednisolone—multiple sclerosis	0.000109	0.00082	CcSEcCtD
Estropipate—Insomnia—Prednisolone—multiple sclerosis	0.000109	0.000813	CcSEcCtD
Estropipate—Alopecia—Prednisone—multiple sclerosis	0.000109	0.000813	CcSEcCtD
Estropipate—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000108	0.00081	CcSEcCtD
Estropipate—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000108	0.000809	CcSEcCtD
Estropipate—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000108	0.000807	CcSEcCtD
Estropipate—Paraesthesia—Prednisolone—multiple sclerosis	0.000108	0.000807	CcSEcCtD
Estropipate—Mental disorder—Prednisone—multiple sclerosis	0.000108	0.000806	CcSEcCtD
Estropipate—Nausea—Azathioprine—multiple sclerosis	0.000108	0.000805	CcSEcCtD
Estropipate—Skin disorder—Methylprednisolone—multiple sclerosis	0.000107	0.000801	CcSEcCtD
Estropipate—Erythema—Prednisone—multiple sclerosis	0.000107	0.000801	CcSEcCtD
Estropipate—Malnutrition—Prednisone—multiple sclerosis	0.000107	0.000801	CcSEcCtD
Estropipate—Asthenia—Mitoxantrone—multiple sclerosis	0.000105	0.000786	CcSEcCtD
Estropipate—Myalgia—Betamethasone—multiple sclerosis	0.000105	0.000783	CcSEcCtD
Estropipate—Myalgia—Dexamethasone—multiple sclerosis	0.000105	0.000783	CcSEcCtD
Estropipate—Anxiety—Dexamethasone—multiple sclerosis	0.000104	0.00078	CcSEcCtD
Estropipate—Anxiety—Betamethasone—multiple sclerosis	0.000104	0.00078	CcSEcCtD
Estropipate—Pain—Prednisolone—multiple sclerosis	0.000103	0.000769	CcSEcCtD
Estropipate—Pharyngitis—Methotrexate—multiple sclerosis	0.000102	0.000763	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000101	0.000753	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.0001	0.000752	CcSEcCtD
Estropipate—Anaphylactic shock—Betamethasone—multiple sclerosis	0.0001	0.00075	CcSEcCtD
Estropipate—Oedema—Dexamethasone—multiple sclerosis	0.0001	0.00075	CcSEcCtD
Estropipate—Oedema—Betamethasone—multiple sclerosis	0.0001	0.00075	CcSEcCtD
Estropipate—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.0001	0.00075	CcSEcCtD
Estropipate—Diarrhoea—Mitoxantrone—multiple sclerosis	0.0001	0.00075	CcSEcCtD
Estropipate—Insomnia—Triamcinolone—multiple sclerosis	9.99e-05	0.000748	CcSEcCtD
Estropipate—Insomnia—Methylprednisolone—multiple sclerosis	9.97e-05	0.000746	CcSEcCtD
Estropipate—Infection—Dexamethasone—multiple sclerosis	9.96e-05	0.000745	CcSEcCtD
Estropipate—Infection—Betamethasone—multiple sclerosis	9.96e-05	0.000745	CcSEcCtD
Estropipate—Paraesthesia—Triamcinolone—multiple sclerosis	9.92e-05	0.000742	CcSEcCtD
Estropipate—Paraesthesia—Methylprednisolone—multiple sclerosis	9.9e-05	0.000741	CcSEcCtD
Estropipate—Visual impairment—Methotrexate—multiple sclerosis	9.89e-05	0.000741	CcSEcCtD
Estropipate—Nervous system disorder—Dexamethasone—multiple sclerosis	9.83e-05	0.000736	CcSEcCtD
Estropipate—Nervous system disorder—Betamethasone—multiple sclerosis	9.83e-05	0.000736	CcSEcCtD
Estropipate—Angioedema—Prednisone—multiple sclerosis	9.77e-05	0.000732	CcSEcCtD
Estropipate—Dyspepsia—Triamcinolone—multiple sclerosis	9.72e-05	0.000728	CcSEcCtD
Estropipate—Erythema multiforme—Methotrexate—multiple sclerosis	9.71e-05	0.000727	CcSEcCtD
Estropipate—Dyspepsia—Methylprednisolone—multiple sclerosis	9.7e-05	0.000726	CcSEcCtD
Estropipate—Vertigo—Prednisone—multiple sclerosis	9.61e-05	0.000719	CcSEcCtD
Estropipate—Eye disorder—Methotrexate—multiple sclerosis	9.59e-05	0.000718	CcSEcCtD
Estropipate—Urticaria—Prednisolone—multiple sclerosis	9.54e-05	0.000714	CcSEcCtD
Estropipate—Cardiac disorder—Methotrexate—multiple sclerosis	9.53e-05	0.000713	CcSEcCtD
Estropipate—Fatigue—Triamcinolone—multiple sclerosis	9.52e-05	0.000713	CcSEcCtD
Estropipate—Fatigue—Methylprednisolone—multiple sclerosis	9.5e-05	0.000711	CcSEcCtD
Estropipate—Pain—Triamcinolone—multiple sclerosis	9.44e-05	0.000707	CcSEcCtD
Estropipate—Angiopathy—Methotrexate—multiple sclerosis	9.31e-05	0.000697	CcSEcCtD
Estropipate—Vomiting—Mitoxantrone—multiple sclerosis	9.31e-05	0.000697	CcSEcCtD
Estropipate—Immune system disorder—Methotrexate—multiple sclerosis	9.27e-05	0.000694	CcSEcCtD
Estropipate—Mediastinal disorder—Methotrexate—multiple sclerosis	9.25e-05	0.000693	CcSEcCtD
Estropipate—Rash—Mitoxantrone—multiple sclerosis	9.23e-05	0.000691	CcSEcCtD
Estropipate—Dermatitis—Mitoxantrone—multiple sclerosis	9.22e-05	0.00069	CcSEcCtD
Estropipate—Headache—Mitoxantrone—multiple sclerosis	9.17e-05	0.000687	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	9.13e-05	0.000684	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	9.13e-05	0.000684	CcSEcCtD
Estropipate—Myalgia—Prednisone—multiple sclerosis	9.1e-05	0.000682	CcSEcCtD
Estropipate—Arthralgia—Prednisone—multiple sclerosis	9.1e-05	0.000682	CcSEcCtD
Estropipate—Anxiety—Prednisone—multiple sclerosis	9.07e-05	0.000679	CcSEcCtD
Estropipate—Alopecia—Methotrexate—multiple sclerosis	9.07e-05	0.000679	CcSEcCtD
Estropipate—Insomnia—Betamethasone—multiple sclerosis	9.06e-05	0.000679	CcSEcCtD
Estropipate—Insomnia—Dexamethasone—multiple sclerosis	9.06e-05	0.000679	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	9.04e-05	0.000677	CcSEcCtD
Estropipate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	9.01e-05	0.000675	CcSEcCtD
Estropipate—Paraesthesia—Dexamethasone—multiple sclerosis	9e-05	0.000674	CcSEcCtD
Estropipate—Paraesthesia—Betamethasone—multiple sclerosis	9e-05	0.000674	CcSEcCtD
Estropipate—Mental disorder—Methotrexate—multiple sclerosis	8.99e-05	0.000673	CcSEcCtD
Estropipate—Erythema—Methotrexate—multiple sclerosis	8.94e-05	0.000669	CcSEcCtD
Estropipate—Malnutrition—Methotrexate—multiple sclerosis	8.94e-05	0.000669	CcSEcCtD
Estropipate—Hypersensitivity—Prednisolone—multiple sclerosis	8.85e-05	0.000662	CcSEcCtD
Estropipate—Dyspepsia—Betamethasone—multiple sclerosis	8.82e-05	0.00066	CcSEcCtD
Estropipate—Dyspepsia—Dexamethasone—multiple sclerosis	8.82e-05	0.00066	CcSEcCtD
Estropipate—Urticaria—Triamcinolone—multiple sclerosis	8.77e-05	0.000657	CcSEcCtD
Estropipate—Urticaria—Methylprednisolone—multiple sclerosis	8.75e-05	0.000655	CcSEcCtD
Estropipate—Body temperature increased—Triamcinolone—multiple sclerosis	8.73e-05	0.000654	CcSEcCtD
Estropipate—Oedema—Prednisone—multiple sclerosis	8.73e-05	0.000653	CcSEcCtD
Estropipate—Anaphylactic shock—Prednisone—multiple sclerosis	8.73e-05	0.000653	CcSEcCtD
Estropipate—Abdominal pain—Methylprednisolone—multiple sclerosis	8.71e-05	0.000652	CcSEcCtD
Estropipate—Nausea—Mitoxantrone—multiple sclerosis	8.7e-05	0.000651	CcSEcCtD
Estropipate—Infection—Prednisone—multiple sclerosis	8.67e-05	0.000649	CcSEcCtD
Estropipate—Gastrointestinal disorder—Betamethasone—multiple sclerosis	8.65e-05	0.000648	CcSEcCtD
Estropipate—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	8.65e-05	0.000648	CcSEcCtD
Estropipate—Back pain—Methotrexate—multiple sclerosis	8.64e-05	0.000647	CcSEcCtD
Estropipate—Fatigue—Dexamethasone—multiple sclerosis	8.64e-05	0.000647	CcSEcCtD
Estropipate—Fatigue—Betamethasone—multiple sclerosis	8.64e-05	0.000647	CcSEcCtD
Estropipate—Pain—Betamethasone—multiple sclerosis	8.57e-05	0.000642	CcSEcCtD
Estropipate—Pain—Dexamethasone—multiple sclerosis	8.57e-05	0.000642	CcSEcCtD
Estropipate—Nervous system disorder—Prednisone—multiple sclerosis	8.56e-05	0.000641	CcSEcCtD
Estropipate—Skin disorder—Prednisone—multiple sclerosis	8.48e-05	0.000635	CcSEcCtD
Estropipate—Gastrointestinal pain—Betamethasone—multiple sclerosis	8.19e-05	0.000614	CcSEcCtD
Estropipate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	8.19e-05	0.000614	CcSEcCtD
Estropipate—Hypersensitivity—Triamcinolone—multiple sclerosis	8.14e-05	0.000609	CcSEcCtD
Estropipate—Hypersensitivity—Methylprednisolone—multiple sclerosis	8.12e-05	0.000608	CcSEcCtD
Estropipate—Vertigo—Methotrexate—multiple sclerosis	8.03e-05	0.000601	CcSEcCtD
Estropipate—Urticaria—Betamethasone—multiple sclerosis	7.96e-05	0.000596	CcSEcCtD
Estropipate—Urticaria—Dexamethasone—multiple sclerosis	7.96e-05	0.000596	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Prednisone—multiple sclerosis	7.95e-05	0.000595	CcSEcCtD
Estropipate—Dizziness—Prednisolone—multiple sclerosis	7.94e-05	0.000595	CcSEcCtD
Estropipate—Asthenia—Triamcinolone—multiple sclerosis	7.92e-05	0.000593	CcSEcCtD
Estropipate—Abdominal pain—Dexamethasone—multiple sclerosis	7.92e-05	0.000593	CcSEcCtD
Estropipate—Abdominal pain—Betamethasone—multiple sclerosis	7.92e-05	0.000593	CcSEcCtD
Estropipate—Body temperature increased—Dexamethasone—multiple sclerosis	7.92e-05	0.000593	CcSEcCtD
Estropipate—Body temperature increased—Betamethasone—multiple sclerosis	7.92e-05	0.000593	CcSEcCtD
Estropipate—Asthenia—Methylprednisolone—multiple sclerosis	7.91e-05	0.000592	CcSEcCtD
Estropipate—Insomnia—Prednisone—multiple sclerosis	7.89e-05	0.000591	CcSEcCtD
Estropipate—Paraesthesia—Prednisone—multiple sclerosis	7.84e-05	0.000587	CcSEcCtD
Estropipate—Pruritus—Triamcinolone—multiple sclerosis	7.81e-05	0.000585	CcSEcCtD
Estropipate—Cough—Methotrexate—multiple sclerosis	7.8e-05	0.000584	CcSEcCtD
Estropipate—Pruritus—Methylprednisolone—multiple sclerosis	7.8e-05	0.000584	CcSEcCtD
Estropipate—ESR2—Gene Expression—HNRNPA1—multiple sclerosis	7.71e-05	0.00323	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—U2AF2—multiple sclerosis	7.71e-05	0.00323	CbGpPWpGaD
Estropipate—Dyspepsia—Prednisone—multiple sclerosis	7.68e-05	0.000575	CcSEcCtD
Estropipate—ALB—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	7.67e-05	0.00321	CbGpPWpGaD
Estropipate—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	7.67e-05	0.00321	CbGpPWpGaD
Estropipate—Myalgia—Methotrexate—multiple sclerosis	7.61e-05	0.00057	CcSEcCtD
Estropipate—Arthralgia—Methotrexate—multiple sclerosis	7.61e-05	0.00057	CcSEcCtD
Estropipate—Rash—Prednisolone—multiple sclerosis	7.57e-05	0.000567	CcSEcCtD
Estropipate—Dermatitis—Prednisolone—multiple sclerosis	7.57e-05	0.000566	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	7.56e-05	0.000566	CcSEcCtD
Estropipate—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	7.55e-05	0.00316	CbGpPWpGaD
Estropipate—Diarrhoea—Methylprednisolone—multiple sclerosis	7.54e-05	0.000564	CcSEcCtD
Estropipate—Fatigue—Prednisone—multiple sclerosis	7.52e-05	0.000563	CcSEcCtD
Estropipate—Headache—Prednisolone—multiple sclerosis	7.52e-05	0.000563	CcSEcCtD
Estropipate—Constipation—Prednisone—multiple sclerosis	7.46e-05	0.000559	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—CCL2—multiple sclerosis	7.42e-05	0.00311	CbGpPWpGaD
Estropipate—Dizziness—Triamcinolone—multiple sclerosis	7.3e-05	0.000547	CcSEcCtD
Estropipate—Anaphylactic shock—Methotrexate—multiple sclerosis	7.29e-05	0.000546	CcSEcCtD
Estropipate—Dizziness—Methylprednisolone—multiple sclerosis	7.29e-05	0.000546	CcSEcCtD
Estropipate—Infection—Methotrexate—multiple sclerosis	7.25e-05	0.000542	CcSEcCtD
Estropipate—ESR1—ATF-2 transcription factor network—IFNG—multiple sclerosis	7.24e-05	0.00303	CbGpPWpGaD
Estropipate—Asthenia—Betamethasone—multiple sclerosis	7.19e-05	0.000538	CcSEcCtD
Estropipate—Asthenia—Dexamethasone—multiple sclerosis	7.19e-05	0.000538	CcSEcCtD
Estropipate—Nervous system disorder—Methotrexate—multiple sclerosis	7.15e-05	0.000536	CcSEcCtD
Estropipate—Gastrointestinal pain—Prednisone—multiple sclerosis	7.14e-05	0.000534	CcSEcCtD
Estropipate—Nausea—Prednisolone—multiple sclerosis	7.13e-05	0.000534	CcSEcCtD
Estropipate—Pruritus—Betamethasone—multiple sclerosis	7.09e-05	0.000531	CcSEcCtD
Estropipate—Pruritus—Dexamethasone—multiple sclerosis	7.09e-05	0.000531	CcSEcCtD
Estropipate—Skin disorder—Methotrexate—multiple sclerosis	7.08e-05	0.00053	CcSEcCtD
Estropipate—Vomiting—Triamcinolone—multiple sclerosis	7.02e-05	0.000526	CcSEcCtD
Estropipate—Vomiting—Methylprednisolone—multiple sclerosis	7.01e-05	0.000525	CcSEcCtD
Estropipate—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	6.98e-05	0.00292	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—PGR—multiple sclerosis	6.97e-05	0.00292	CbGpPWpGaD
Estropipate—Rash—Triamcinolone—multiple sclerosis	6.96e-05	0.000521	CcSEcCtD
Estropipate—Dermatitis—Triamcinolone—multiple sclerosis	6.96e-05	0.000521	CcSEcCtD
Estropipate—Rash—Methylprednisolone—multiple sclerosis	6.95e-05	0.00052	CcSEcCtD
Estropipate—Dermatitis—Methylprednisolone—multiple sclerosis	6.94e-05	0.00052	CcSEcCtD
Estropipate—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	6.94e-05	0.0029	CbGpPWpGaD
Estropipate—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	6.94e-05	0.0029	CbGpPWpGaD
Estropipate—Urticaria—Prednisone—multiple sclerosis	6.93e-05	0.000519	CcSEcCtD
Estropipate—Headache—Triamcinolone—multiple sclerosis	6.92e-05	0.000518	CcSEcCtD
Estropipate—Headache—Methylprednisolone—multiple sclerosis	6.9e-05	0.000517	CcSEcCtD
Estropipate—Body temperature increased—Prednisone—multiple sclerosis	6.9e-05	0.000517	CcSEcCtD
Estropipate—Abdominal pain—Prednisone—multiple sclerosis	6.9e-05	0.000517	CcSEcCtD
Estropipate—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	6.87e-05	0.00287	CbGpPWpGaD
Estropipate—Diarrhoea—Dexamethasone—multiple sclerosis	6.86e-05	0.000513	CcSEcCtD
Estropipate—Diarrhoea—Betamethasone—multiple sclerosis	6.86e-05	0.000513	CcSEcCtD
Estropipate—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.84e-05	0.00286	CbGpPWpGaD
Estropipate—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.84e-05	0.00286	CbGpPWpGaD
Estropipate—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	6.65e-05	0.000498	CcSEcCtD
Estropipate—Dizziness—Betamethasone—multiple sclerosis	6.63e-05	0.000496	CcSEcCtD
Estropipate—Dizziness—Dexamethasone—multiple sclerosis	6.63e-05	0.000496	CcSEcCtD
Estropipate—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	6.62e-05	0.00277	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—IL4—multiple sclerosis	6.61e-05	0.00277	CbGpPWpGaD
Estropipate—ESR1—FOXM1 transcription factor network—MYC—multiple sclerosis	6.6e-05	0.00276	CbGpPWpGaD
Estropipate—Insomnia—Methotrexate—multiple sclerosis	6.6e-05	0.000494	CcSEcCtD
Estropipate—Nausea—Triamcinolone—multiple sclerosis	6.56e-05	0.000491	CcSEcCtD
Estropipate—Paraesthesia—Methotrexate—multiple sclerosis	6.55e-05	0.00049	CcSEcCtD
Estropipate—Nausea—Methylprednisolone—multiple sclerosis	6.55e-05	0.00049	CcSEcCtD
Estropipate—Somnolence—Methotrexate—multiple sclerosis	6.48e-05	0.000485	CcSEcCtD
Estropipate—ESR1—LKB1 signaling events—MYC—multiple sclerosis	6.48e-05	0.00271	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—IFNG—multiple sclerosis	6.46e-05	0.0027	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	6.45e-05	0.0027	CbGpPWpGaD
Estropipate—Hypersensitivity—Prednisone—multiple sclerosis	6.43e-05	0.000481	CcSEcCtD
Estropipate—Dyspepsia—Methotrexate—multiple sclerosis	6.42e-05	0.000481	CcSEcCtD
Estropipate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	6.41e-05	0.00268	CbGpPWpGaD
Estropipate—Vomiting—Dexamethasone—multiple sclerosis	6.37e-05	0.000477	CcSEcCtD
Estropipate—Vomiting—Betamethasone—multiple sclerosis	6.37e-05	0.000477	CcSEcCtD
Estropipate—Rash—Betamethasone—multiple sclerosis	6.32e-05	0.000473	CcSEcCtD
Estropipate—Rash—Dexamethasone—multiple sclerosis	6.32e-05	0.000473	CcSEcCtD
Estropipate—Dermatitis—Dexamethasone—multiple sclerosis	6.31e-05	0.000473	CcSEcCtD
Estropipate—Dermatitis—Betamethasone—multiple sclerosis	6.31e-05	0.000473	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—IFNG—multiple sclerosis	6.31e-05	0.00264	CbGpPWpGaD
Estropipate—Gastrointestinal disorder—Methotrexate—multiple sclerosis	6.3e-05	0.000471	CcSEcCtD
Estropipate—Fatigue—Methotrexate—multiple sclerosis	6.29e-05	0.000471	CcSEcCtD
Estropipate—Headache—Betamethasone—multiple sclerosis	6.28e-05	0.00047	CcSEcCtD
Estropipate—Headache—Dexamethasone—multiple sclerosis	6.28e-05	0.00047	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	6.27e-05	0.00262	CbGpPWpGaD
Estropipate—Asthenia—Prednisone—multiple sclerosis	6.26e-05	0.000469	CcSEcCtD
Estropipate—Pain—Methotrexate—multiple sclerosis	6.24e-05	0.000467	CcSEcCtD
Estropipate—Pruritus—Prednisone—multiple sclerosis	6.17e-05	0.000462	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	6.14e-05	0.00257	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—ZFP36L1—multiple sclerosis	6.09e-05	0.00255	CbGpPWpGaD
Estropipate—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	6.07e-05	0.00254	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	6e-05	0.00251	CbGpPWpGaD
Estropipate—Diarrhoea—Prednisone—multiple sclerosis	5.97e-05	0.000447	CcSEcCtD
Estropipate—Gastrointestinal pain—Methotrexate—multiple sclerosis	5.96e-05	0.000447	CcSEcCtD
Estropipate—Nausea—Betamethasone—multiple sclerosis	5.95e-05	0.000446	CcSEcCtD
Estropipate—Nausea—Dexamethasone—multiple sclerosis	5.95e-05	0.000446	CcSEcCtD
Estropipate—ESR1—Signaling by ERBB4—CD86—multiple sclerosis	5.89e-05	0.00246	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	5.88e-05	0.00246	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.83e-05	0.00244	CbGpPWpGaD
Estropipate—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	5.81e-05	0.00243	CbGpPWpGaD
Estropipate—Urticaria—Methotrexate—multiple sclerosis	5.79e-05	0.000434	CcSEcCtD
Estropipate—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	5.78e-05	0.00242	CbGpPWpGaD
Estropipate—Dizziness—Prednisone—multiple sclerosis	5.77e-05	0.000432	CcSEcCtD
Estropipate—Body temperature increased—Methotrexate—multiple sclerosis	5.77e-05	0.000432	CcSEcCtD
Estropipate—Abdominal pain—Methotrexate—multiple sclerosis	5.77e-05	0.000432	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—IL2—multiple sclerosis	5.74e-05	0.0024	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	5.72e-05	0.00239	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	5.72e-05	0.00239	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—IL2—multiple sclerosis	5.61e-05	0.00235	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—ZNF746—multiple sclerosis	5.61e-05	0.00235	CbGpPWpGaD
Estropipate—Vomiting—Prednisone—multiple sclerosis	5.55e-05	0.000415	CcSEcCtD
Estropipate—ALB—Hemostasis—SELPLG—multiple sclerosis	5.52e-05	0.00231	CbGpPWpGaD
Estropipate—ALB—Hemostasis—MERTK—multiple sclerosis	5.52e-05	0.00231	CbGpPWpGaD
Estropipate—ALB—Hemostasis—CD58—multiple sclerosis	5.52e-05	0.00231	CbGpPWpGaD
Estropipate—Rash—Prednisone—multiple sclerosis	5.5e-05	0.000412	CcSEcCtD
Estropipate—Dermatitis—Prednisone—multiple sclerosis	5.5e-05	0.000412	CcSEcCtD
Estropipate—Headache—Prednisone—multiple sclerosis	5.47e-05	0.000409	CcSEcCtD
Estropipate—Hypersensitivity—Methotrexate—multiple sclerosis	5.37e-05	0.000402	CcSEcCtD
Estropipate—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	5.36e-05	0.00224	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	5.36e-05	0.00224	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—IL1B—multiple sclerosis	5.33e-05	0.00223	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—MMP9—multiple sclerosis	5.31e-05	0.00222	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	5.28e-05	0.00221	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	5.28e-05	0.00221	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—ICAM1—multiple sclerosis	5.25e-05	0.0022	CbGpPWpGaD
Estropipate—Asthenia—Methotrexate—multiple sclerosis	5.23e-05	0.000392	CcSEcCtD
Estropipate—Nausea—Prednisone—multiple sclerosis	5.18e-05	0.000388	CcSEcCtD
Estropipate—Pruritus—Methotrexate—multiple sclerosis	5.16e-05	0.000386	CcSEcCtD
Estropipate—ESR1—Gene Expression—PTBP1—multiple sclerosis	5.13e-05	0.00215	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	5.04e-05	0.00211	CbGpPWpGaD
Estropipate—Diarrhoea—Methotrexate—multiple sclerosis	4.99e-05	0.000374	CcSEcCtD
Estropipate—ESR1—ATF-2 transcription factor network—MAPK1—multiple sclerosis	4.92e-05	0.00206	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	4.91e-05	0.00205	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—VDR—multiple sclerosis	4.87e-05	0.00204	CbGpPWpGaD
Estropipate—Dizziness—Methotrexate—multiple sclerosis	4.82e-05	0.000361	CcSEcCtD
Estropipate—ESR2—Gene Expression—PABPC1—multiple sclerosis	4.72e-05	0.00198	CbGpPWpGaD
Estropipate—ESR1—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	4.71e-05	0.00197	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—CCL2—multiple sclerosis	4.7e-05	0.00197	CbGpPWpGaD
Estropipate—Vomiting—Methotrexate—multiple sclerosis	4.64e-05	0.000347	CcSEcCtD
Estropipate—Rash—Methotrexate—multiple sclerosis	4.6e-05	0.000344	CcSEcCtD
Estropipate—Dermatitis—Methotrexate—multiple sclerosis	4.59e-05	0.000344	CcSEcCtD
Estropipate—Headache—Methotrexate—multiple sclerosis	4.57e-05	0.000342	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—MYC—multiple sclerosis	4.49e-05	0.00188	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—TGFB1—multiple sclerosis	4.48e-05	0.00187	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—STAT3—multiple sclerosis	4.47e-05	0.00187	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.41e-05	0.00185	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—MAPK1—multiple sclerosis	4.39e-05	0.00184	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—MYC—multiple sclerosis	4.39e-05	0.00183	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—BCHE—multiple sclerosis	4.38e-05	0.00183	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	4.38e-05	0.00183	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—TGFB1—multiple sclerosis	4.38e-05	0.00183	CbGpPWpGaD
Estropipate—Nausea—Methotrexate—multiple sclerosis	4.33e-05	0.000324	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.31e-05	0.0018	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—CD80—multiple sclerosis	4.29e-05	0.0018	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	4.27e-05	0.00179	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—RPL5—multiple sclerosis	4.26e-05	0.00178	CbGpPWpGaD
Estropipate—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.24e-05	0.00177	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	4.17e-05	0.00175	CbGpPWpGaD
Estropipate—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	4.06e-05	0.0017	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—MAPK1—multiple sclerosis	4.06e-05	0.0017	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—IFNG—multiple sclerosis	4e-05	0.00167	CbGpPWpGaD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	3.9e-05	0.00163	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.9e-05	0.00163	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.9e-05	0.00163	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—HNRNPA1—multiple sclerosis	3.89e-05	0.00163	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—U2AF2—multiple sclerosis	3.89e-05	0.00163	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.89e-05	0.00163	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.81e-05	0.00159	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.81e-05	0.00159	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.81e-05	0.00159	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—IL6—multiple sclerosis	3.78e-05	0.00158	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	3.73e-05	0.00156	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	3.73e-05	0.00156	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	3.63e-05	0.00152	CbGpPWpGaD
Estropipate—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.63e-05	0.00152	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—TYK2—multiple sclerosis	3.63e-05	0.00152	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—SRM—multiple sclerosis	3.6e-05	0.00151	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—IL1B—multiple sclerosis	3.56e-05	0.00149	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—IL2—multiple sclerosis	3.55e-05	0.00149	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—PGR—multiple sclerosis	3.51e-05	0.00147	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.49e-05	0.00146	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.44e-05	0.00144	CbGpPWpGaD
Estropipate—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.44e-05	0.00144	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PLEK—multiple sclerosis	3.41e-05	0.00143	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—PGR—multiple sclerosis	3.36e-05	0.0014	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	3.33e-05	0.00139	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	3.31e-05	0.00139	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—IL6—multiple sclerosis	3.3e-05	0.00138	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	3.18e-05	0.00133	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	3.17e-05	0.00133	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.12e-05	0.0013	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.12e-05	0.0013	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.08e-05	0.00129	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—ZFP36L1—multiple sclerosis	3.07e-05	0.00129	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.95e-05	0.00124	CbGpPWpGaD
Estropipate—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.94e-05	0.00123	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—LINGO1—multiple sclerosis	2.91e-05	0.00122	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	2.83e-05	0.00118	CbGpPWpGaD
Estropipate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.8e-05	0.00117	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.66e-05	0.00111	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.66e-05	0.00111	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	2.59e-05	0.00108	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—TNF—multiple sclerosis	2.59e-05	0.00108	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	2.59e-05	0.00108	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	2.56e-05	0.00107	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CYP27B1—multiple sclerosis	2.54e-05	0.00106	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CYP24A1—multiple sclerosis	2.54e-05	0.00106	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	2.54e-05	0.00106	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TAGAP—multiple sclerosis	2.53e-05	0.00106	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—VDR—multiple sclerosis	2.46e-05	0.00103	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	2.41e-05	0.00101	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	2.41e-05	0.00101	CbGpPWpGaD
Estropipate—ALB—Metabolism—SRM—multiple sclerosis	2.41e-05	0.00101	CbGpPWpGaD
Estropipate—ALB—Hemostasis—SELE—multiple sclerosis	2.4e-05	0.00101	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—PABPC1—multiple sclerosis	2.38e-05	0.000997	CbGpPWpGaD
Estropipate—ALB—Platelet degranulation—TGFB1—multiple sclerosis	2.37e-05	0.000993	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	2.37e-05	0.000992	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—VDR—multiple sclerosis	2.34e-05	0.000981	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.33e-05	0.000977	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GPC5—multiple sclerosis	2.32e-05	0.000971	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	2.32e-05	0.00097	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—MAPK1—multiple sclerosis	2.31e-05	0.000965	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	2.3e-05	0.000964	CbGpPWpGaD
Estropipate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.27e-05	0.000949	CbGpPWpGaD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	2.26e-05	0.000946	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—S1PR1—multiple sclerosis	2.21e-05	0.000924	CbGpPWpGaD
Estropipate—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.19e-05	0.000914	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—RPL5—multiple sclerosis	2.15e-05	0.000899	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—GPC5—multiple sclerosis	2.15e-05	0.000899	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—IL6—multiple sclerosis	2.09e-05	0.000873	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.06e-05	0.000863	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	2.05e-05	0.000859	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—SRM—multiple sclerosis	1.97e-05	0.000825	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.96e-05	0.000822	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.96e-05	0.00082	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—MYC—multiple sclerosis	1.94e-05	0.00081	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—RRM1—multiple sclerosis	1.92e-05	0.000804	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.92e-05	0.000804	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—RGS1—multiple sclerosis	1.88e-05	0.000786	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.83e-05	0.000766	CbGpPWpGaD
Estropipate—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.83e-05	0.000764	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—GPR65—multiple sclerosis	1.78e-05	0.000745	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—IL6—multiple sclerosis	1.77e-05	0.000742	CbGpPWpGaD
Estropipate—ALB—Hemostasis—ITGA4—multiple sclerosis	1.74e-05	0.000727	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IFNB1—multiple sclerosis	1.73e-05	0.000722	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP24A1—multiple sclerosis	1.7e-05	0.00071	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP27B1—multiple sclerosis	1.7e-05	0.00071	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—PGR—multiple sclerosis	1.69e-05	0.000708	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SRM—multiple sclerosis	1.68e-05	0.000705	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.67e-05	0.0007	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.66e-05	0.000694	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	1.66e-05	0.000694	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CXCL13—multiple sclerosis	1.63e-05	0.000681	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCR1—multiple sclerosis	1.63e-05	0.000681	CbGpPWpGaD
Estropipate—CYP1A2—Biological oxidations—POMC—multiple sclerosis	1.56e-05	0.000653	CbGpPWpGaD
Estropipate—ALB—Metabolism—GPC5—multiple sclerosis	1.55e-05	0.000649	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.39e-05	0.000581	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.39e-05	0.000581	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.36e-05	0.000568	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.35e-05	0.000565	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SRM—multiple sclerosis	1.3e-05	0.000544	CbGpPWpGaD
Estropipate—ALB—Metabolism—RRM1—multiple sclerosis	1.29e-05	0.000538	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	1.28e-05	0.000536	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.27e-05	0.000531	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.2e-05	0.000504	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IL2RA—multiple sclerosis	1.19e-05	0.000497	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.19e-05	0.000497	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.19e-05	0.000497	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—VDR—multiple sclerosis	1.18e-05	0.000495	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCL3—multiple sclerosis	1.16e-05	0.000485	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.16e-05	0.000485	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PTGER4—multiple sclerosis	1.12e-05	0.000467	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.11e-05	0.000465	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—BCHE—multiple sclerosis	1.1e-05	0.000462	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PGR—multiple sclerosis	1.1e-05	0.00046	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.09e-05	0.000454	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CXCR3—multiple sclerosis	1.08e-05	0.000451	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CD28—multiple sclerosis	1.07e-05	0.000447	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.05e-05	0.000441	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.05e-05	0.00044	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCR2—multiple sclerosis	1.05e-05	0.000439	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.03e-05	0.000432	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.98e-06	0.000417	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—MYC—multiple sclerosis	9.76e-06	0.000408	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CNR1—multiple sclerosis	9.68e-06	0.000405	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—MYC—multiple sclerosis	9.32e-06	0.00039	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	9.16e-06	0.000383	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	9.16e-06	0.000383	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—RRM1—multiple sclerosis	8.99e-06	0.000376	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CXCL10—multiple sclerosis	8.72e-06	0.000365	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.57e-06	0.000359	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GPC5—multiple sclerosis	8.38e-06	0.00035	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.17e-06	0.000342	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CD86—multiple sclerosis	7.63e-06	0.000319	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCL5—multiple sclerosis	7.51e-06	0.000314	CbGpPWpGaD
Estropipate—ALB—Metabolism—BCHE—multiple sclerosis	7.39e-06	0.000309	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.02e-06	0.000293	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.98e-06	0.000292	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IL2—multiple sclerosis	6.96e-06	0.000291	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SPP1—multiple sclerosis	6.95e-06	0.000291	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—RRM1—multiple sclerosis	6.94e-06	0.00029	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCR5—multiple sclerosis	6.76e-06	0.000283	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL2RA—multiple sclerosis	6.66e-06	0.000279	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—APOE—multiple sclerosis	6.64e-06	0.000278	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.4e-06	0.000268	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—APOE—multiple sclerosis	6.15e-06	0.000257	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—BCHE—multiple sclerosis	6.05e-06	0.000253	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.99e-06	0.000251	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—POMC—multiple sclerosis	5.71e-06	0.000239	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CD80—multiple sclerosis	5.56e-06	0.000233	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.47e-06	0.000229	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TGFB1—multiple sclerosis	5.43e-06	0.000227	CbGpPWpGaD
Estropipate—ALB—Hemostasis—MAPK1—multiple sclerosis	5.32e-06	0.000223	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—POMC—multiple sclerosis	5.29e-06	0.000221	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ALB—multiple sclerosis	5.2e-06	0.000218	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCL2—multiple sclerosis	5.17e-06	0.000216	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—BCHE—multiple sclerosis	5.17e-06	0.000216	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MYC—multiple sclerosis	4.7e-06	0.000197	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TYK2—multiple sclerosis	4.7e-06	0.000196	CbGpPWpGaD
Estropipate—ALB—Metabolism—APOE—multiple sclerosis	4.44e-06	0.000186	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.99e-06	0.000167	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL2—multiple sclerosis	3.91e-06	0.000163	CbGpPWpGaD
Estropipate—ALB—Metabolism—POMC—multiple sclerosis	3.82e-06	0.00016	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MMP9—multiple sclerosis	3.7e-06	0.000155	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—APOE—multiple sclerosis	3.64e-06	0.000152	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—STAT3—multiple sclerosis	3.29e-06	0.000138	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—POMC—multiple sclerosis	3.12e-06	0.000131	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—APOE—multiple sclerosis	3.11e-06	0.00013	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MYC—multiple sclerosis	3.06e-06	0.000128	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TGFB1—multiple sclerosis	3.05e-06	0.000128	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAPK1—multiple sclerosis	2.99e-06	0.000125	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ALB—multiple sclerosis	2.85e-06	0.000119	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—POMC—multiple sclerosis	2.67e-06	0.000112	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ALB—multiple sclerosis	2.43e-06	0.000102	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—APOE—multiple sclerosis	2.4e-06	0.0001	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL6—multiple sclerosis	2.3e-06	9.61e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—POMC—multiple sclerosis	2.06e-06	8.62e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ALB—multiple sclerosis	1.88e-06	7.86e-05	CbGpPWpGaD
